Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: Single center observational experience

International Journal of Cardiology

Volumn 172, Issue 1, 2014, Pages 64-71

  Frigerio, Maria ^a   Lunati, Maurizio ^a   Pasqualucci, Daniele ^b   Vargiu, Sara ^a   Foti, Grazia ^a   Pedretti, Stefano ^a   Vittori, Claudia ^a   Cattafi, Giuseppe ^a   Magenta, Giovanni ^a   Campo, Claudia ^c   Bisetti, Silvia ^c   Mercuro, Giuseppe ^d  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b BROTZU HOSPITAL   (Italy)

^c Medtronic Italia   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Cardiac resynchronization therapy; Heart failure; Reverse remodeling; Sudden cardiac death

Indexed keywords

AGED; CARDIAC RESYNCHRONIZATION THERAPY; DEATH, SUDDEN, CARDIAC; DISEASE FREE SURVIVAL; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; DEATH, SUDDEN, CARDIAC; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84894092778     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.005     Document Type: Article

References (42)

1. M.R. Bristow, L.A. Saxon, and J. Boehmer et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
2. J.G. Cleland, J.C. Daubert, and E. Erdmann et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
3. J.G. Cleland, J.C. Daubert, and E. Erdmann et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 27 2006 1928 1932
4. W.T. Abraham, J.B. Young, and A.R. Leon et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter- defibrillator, and mildly symptomatic chronic heart failure Circulation 110 2004 2864 2868
5. C. Linde, W.T. Abraham, M.R. Gold, M. St John Sutton, S. Ghio, and C. Daubert Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 2008 1834 1843
6. C. Daubert, M.R. Gold, and W.T. Abraham et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial J Am Coll Cardiol 54 2009 1837 1846
7. A.J. Moss, W.J. Hall, and D.S. Cannom et al. Cardiac resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
8. A.S. Tang, G.A. Wells, and M. Talajic et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
9. D.J. Bradley, E.A. Bradley, and K.L. Baughman et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials JAMA 289 2003 730 740
10. C.M. Yu, G.B. Bleeker, and J.W. Fung et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy Circulation 112 2005 1580 1586
11. L.J. Anderson, C. Miyazaki, G.R. Sutherland, and J.K. Oh Patient selection and echocardiographic assessment of dyssynchrony in cardiac resynchronization therapy Circulation 117 2008 2009 2023
12. L. Di Biase, A. Auricchio, and A. Sorgente et al. The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy Eur Heart J 29 2008 2497 2505
13. C. Ypenberg, R.J. vanBommel, and C.J.W. Borleffs et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up J Am Coll Cardiol 53 2009 483 490
14. S.D. Solomon, E. Foster, and M. Bourgoun et al. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy Circulation 122 2010 985 992
15. P.W.X. Foley, S. Chalil, K. Khadjooi, N. Irwin, R.E.A. Smith, and F. Leyva Left ventricular reverse remodelling, long-term clinical outcome, and mode of death after cardiac resynchronization therapy Eur J Heart Fail 13 2011 43 51
16. S.M. Markowitz, J.M. Lewen, and C.J. Wiggenhorn et al. Relationship of reverse anatomical remodeling and ventricular arrhythmias after cardiac resynchronization J Cardiovasc Electrophysiol 20 2009 293 298
17. M.R. Gold, C. Linde, W.T. Abraham, A. Gardiwal, and J.C. Daubert The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure Heart Rhythm 8 2011 679 684
18. A. Barsheshet, P.J. Wang, and A.J. Moss et al. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy) J Am Coll Cardiol 57 2011 2416 2423
19. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
20. J.P. Vandenbroucke, E. von Elm, and D.G. Altman et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration Ann Intern Med 147 2007 W163 W194
21. S. Ghio, N. Freemantle, and A. Serio et al. Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study) Eur J Echocardiogr 7 2006 373 378
22. N.B. Schiller, P.M. Shah, and M. Crawford et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
23. R.J. Myerburg, and A. Castellanos Cardiac arrest and sudden cardiac death E. Braunwald, Heart disease: a textbook of cardiovascular medicine 1997 WB Saunders Publishing Co New York 742 779
24. M.S. Sutton, M.A. Pfeffer, and T. Plappert et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril Circulation 89 1994 68 75
25. M. Packer, W.S. Colucci, and J.D. Sackner-Bernstein et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise Circulation 94 1996 2793 2799
26. L.A. Pires, S. Ghio, E.S. Chung, L. Tavazzi, W.T. Abraham, and B. Gerritse Relationship between acute improvement in left ventricular function to 6-month outcomes after cardiac resynchronization therapy in patients with chronic heart failure Congest Heart Fail 17 2011 65 70
27. J. Steffel, G. Milosevic, and A. Hürlimann et al. Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre Heart 97 2011 1668 1674
28. M Gasparini, C. Muto, and S. Iacopino et al. Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identify cardiac resynchronization therapy responders: data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study Am Heart J 163 2012 422 429
29. A.P. Maggioni, G. Zuanetti, and M.G. Franzosi et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results Circulation 87 1993 312 322
30. S.D. Solomon, S. Zelenkofske, and J.J.V. McMurray et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both N Engl J Med 352 2005 2581 2588
31. A.J. Moss, W. Zareba, and W.J. Hall et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
32. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
33. B. Bozkurt, I. Agoston, and A.A. Knowlton Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines J Am Coll Cardiol 41 2003 211 214
34. W.J. Rogers, D.E. Johnstone, and S. Yusuf et al. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators J Am Coll Cardiol 23 1994 393 400
35. F. Follath, J.G. Cleland, and H. Just et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial Lancet 360 2002 196 202
36. A. Arshad, A.J. Moss, and E. Foster et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial J Am Coll Cardiol 57 2011 813 820
37. N. Bogale, S. Priori, and J.G. Cleland et al. The European CRT survey: 1 year (9-15 months) follow-up results Eur J Heart Fail 14 2012 61 73
38. L.A. Saxon, M.R. Bristow, and J. Boehmer et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial Circulation 114 2006 2766 2772
39. R.F. Pedretti, A. Laporta, and S. Masnaghetti et al. Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up G Ital Cardiol 11 10 Suppl. 1 2010 134S 136S
40. J.B. vanRees, C.J. Borleffs, and M.K. de Bie et al. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality J Am Coll Cardiol 57 2011 556 562
41. K.A. Ellenbogen, J.H. Levine, and R.D. Berger et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 113 2006 776 782
42. J.B. vanRees, C.J. Borleffs, and G.H. vanWelsenes Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score Heart 98 11 Jun 2012 872 877